Dear readers,

At the 4th ASCERTAIN Consortium meeting, held during the European Hematology Association (EHA) Congress in Madrid, we reached an important milestone by presenting 1.5 years of progress to our international advisory board. Our discussions centered around key findings from our scoping reviews and stakeholder inputs on...
Read more

Ethical and Secure Data Use in Health Research

Effective data management is a cornerstone of modern health research, especially when addressing privacy and compliance with ethical standards. In the digital health ecosystem, where data flows rapidly and innovations are constantly emerging, ASCERTAIN is committed to ensuring that data handling is both ethical and...
Read more

Recent site visits have highlighted the dynamic and collaborative efforts of the ASCERTAIN project in advancing precision cancer medicine (PCM) and health technology assessments (HTA) in Norway.

On April 12th, PhD student Yansi Wu presented initial findings from our Structured Expert Elicitation (SEE) project to the CONNECT group, a consortium focused on overcoming...
Read more

Greener pharmaceuticals: policies for an environmentally sustainable pharmaceutical system

The webinar on greener pharmaceuticals, hosted by the Pharmacoeconomics Department at Gesundheit Österreich, emphasized the role of pharmaceuticals in transitioning towards a planetary health approach. The event explored policy measures like health technology assessment and public procurement of medicines to promote sustainable health systems. It drew...
Read more

"Everyone is entitled to the best treatment, no matter where you live"

In many countries, patients have to wait a long time before expensive medicine become available, reducing their chance of survival. This is unfair and has to change, says professor of Health Technology Assessment Carin Uyl-de Groot at Erasmus School of Health Policy &...
Read more

Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris’s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.

Solidaris very successfully presented its bill for fair drug prices as several parties immediately...
Read more

The recent EAA Spring Convention, themed 'Finding the Right Balance,' held at Erasmus Universiteit Rotterdam, brought together industry experts and stakeholders to explore the complexities of navigating the European Union's market access for medicines and devices. Co-organized by ASCERTAIN alongside Maureen Rutten-van Mölken, Joerg Ruof, and Elaine Julian, the convention delved into key issues surrounding Health Technology Assessment...
Read more

Dear readers,

Six months have passed since our last newsletter, and a lot has happened.

In this second issue of the ASCERTAIN newsletter, we are pleased to present an interview with Maria Piggin, founder and chair of the PNH Global Alliance. Maria Piggin talks...
Read more

A catalyst for collaborative advances in cancer immunotherapy

On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting. His journey began by attending the meeting of the T2EVOLVE consortium, an EU-funded initiative pioneering collaboration between leading scientists and industry in cancer immunotherapy. This ground-breaking alliance aims to...
Read more

Navigating Challenges in Health Economics and Outcomes Research

Last week, Carin Uyl-de Groot, Mirjana Huić, Nicolas Xander and Isabelle Durand-Zaleski presented ASCERTAIN in Copenhagen. Their session was entitled: "Horizon Europe Project Ascertain: Supporting a sustainable and transparent EU HTA regulatory framework, accessibility of innovative technologies and health equity".

In this session,...
Read more